The Centers for Disease Control and Prevention (“CDC”) Advisory Committee on Immunization Practices (“ACIP”) develops recommendations for how vaccinations are used to control disease in the United States. Earlier this month, the ACIP voted 8-3 to narrow the CDC’s guidance on newborn hepatitis B vaccination administration. Hepatitis B is an infection that causes inflammation in the
For those operating in the European Union, the list of digital technology laws is becoming daunting. Compliance with GDPR to the AI Act — with stops along the way for the ePrivacy Directive and many more – is a significant undertaking. To simplify this confusion, the European Commission is proposing modifications to many of its
The rapid advancement of artificial intelligence (“AI”) has spurred remarkable innovation for the healthcare industry, while also resulting in swiftly emerging regulatory frameworks. On October 13, 2025, Governor Gavin Newsom signed into law California Senate Bill 243 (“SB 243”) – the first law in the nation to address the “human interface” of AI chatbots, especially
The Centers for Medicare and Medicaid Services (“CMS”) recently announced the first six participating states in the Wasteful and Inappropriate Service Reduction (“WISeR”) Model that will begin on January 1, 2026: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.[1] As its hallmark objective, the Model aims to refine prior authorization processes for traditional fee-for-service
On December 2, a non-governmental policy organization affiliated with Democratic state attorneys general announced the formation of a Consumer Protection and Affordability Working Group. The initiative will be supported by participating attorneys general and advised by Rohit Chopra, the former Director of the Consumer Financial Protection Bureau and former Commissioner at the Federal Trade Commission.
On December 1, 2025, the Federal Reserve released its semiannual Supervision and Regulation Report describing a broad reduction in outstanding supervisory findings across institutions of all sizes. The report indicates declines among global systemically important banks, large foreign and domestic banking organizations, and small and midsize banks, reflecting a shift in the Fed’s supervisory posture.
The European Data Protection Supervisor (EDPS) AI guidance for EU institutions has lessons for businesses. This includes when inputting personal information into these tools. The recommendations from the guidance fall into five categories, which businesses can take as potential principles. Namely:
In early August, Illinois enacted the Wellness and Oversight for Psychological Resources Act (HB 1806, or the “Act”), making it the first state to pass a law regulating the use of AI[1] in the delivery of therapy and psychotherapy services. The Act, which took immediate effect, imposes guardrails on the use of AI to
The U.S. Patent and Trademark Office (USPTO) has issued updated examination guidance (“New Guidance”) on inventorship in applications involving artificial intelligence (AI). The document rescinds and replaces the February 13, 2024 guidance and clarifies how inventorship should be determined when AI is used in the inventive process. The New Guidance jettisons the Pannu test for
Illinois employers are reminded that a law addressing the use of AI in the workplace is set to take effect January 1, 2026.